Bixiye
QP75-18 2018 Blue Cross Blue Shield MHCP Migration and New Initiatives Training
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 07, 2018
Natiijooyinka Raadinta
Soo bandhiga 2981 - 2990 ee natiijooyinka 5048
Bixiye
QP93-18 Technical Issues with Authorization and Referral Tool on Availity Resolved
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2018
Bixiye
QP79-18 Addition of Drug to the Hereditary Angioedema Prior Authorization with Quantity Limit Program
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 21, 2018
Bixiye
QP57-18 New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary Angioedema
Taariikhda dhaqangalka Barnaamijka: Jul 19, 2018
Bixiye
QP49-18 Pharmacy Benefit Update - New Drug-Related Step Therapy (ST) with Quantity Limit (QL) Criteria: Triptans
Taariikhda wax ku ool ah ee barnaamijka: Jun 13, 2018
Bixiye
QP83-18 Cotiviti Healthcare Creates a Provider Connection Portal for Providers
Taariikhda uu dhaqangalayo barnaamijka: Okt 11, 2018
Bixiye
QP77-18 Pharmacy Benefit Exclusion for Onpattro (patisiran) Lipid Complex Intravenous (IV) Injection
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 11, 2018
Bixiye
QP39-18 Provider Cost Data Update
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
QP44-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Lyrica CR (pregabalin Extended Release)
Taariikhda wax ku ool ah ee barnaamijka: Jun 06, 2018
Bixiye
QP40-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Selective Serotonin Inverse Agonist (SSIA)
Taariikhda uu dhaqangalayo Barnaamijka: May 31, 2018